期刊文献+

普罗布考联合阿托伐他汀对高密度脂蛋白亚型和甘油三酯水平的影响 被引量:5

Effects of probucol combined with atorvastatin on the levels of high density lipoprotein subfractions and triglyceride
下载PDF
导出
摘要 目的探讨普罗布考联合阿托伐他汀对急性冠状动脉综合征合并2型糖尿病惠者HDL-C亚型和TG水平的影响。方法选取急性冠状动脉综合征合并2型糖尿病患者120例,随机分为治疗组和对照组各60例,治疗组给予普罗布考500 mg,2次/d;阿托伐他汀20 mg,1次/晚;对照组给予阿托伐他汀20 mg,1次/晚。2组均常规使用硝酸酯类和抗血小板药物。治疗前及治疗3个月后分别检测TG、TC、LDL-C、HDL-C、HDL_2、HDL_3。结果与治疗前比较,治疗3个月后,2组患者TG、TC、LDL-C均有下降(P<0.05),治疗组下降更为明显(P<0.01),治疗组患者HDL-C和HDL_2明显下降,HDL_3、HDL_3/HDL-C明显升高(P<0.05),对照组HDLC明显升高(P<0.05)。与对照组治疗后比较,治疗组TG、TC、LDL-C、HDL-C、HDL_2明显下降(P<0.05),HDL_3、HDL_3/HDL-C明显升高(P<0.05)。结论普罗布考联合阿托伐他汀治疗急性冠状动脉综合征合并2型糖尿病,可更好降低TG、TC、LDL-C,虽然同时HDL-C总量有所下降,但逆向转运TC能力更强的HDL_3却增加。 Objective To probe the impact of probucol combined with atorvastatin on the levels of HDL-C subfractions and TG in ACS patients with type-2 diabetes. Methods 120 patients with ACS and type-2 diabetes were divided randomly into a treatment group and a control group of 60 cases each. The treatment group was treated with probucol 500 mg, bid,atorvastatin 20 mg, qn; the control group was treated with atorvastatin 20 mg, qn. Nitrate esters and antiplatelet drugs were used in both groups. At the beginning of the treatment and after three months of treatment, the patients' TG,TC,LDL-C,HDL-C, HDL2 and HDL3 were examined. Results Compared with before treatment,TG,TC and LDL-C of both groups decreased after three months of treatment (P 〈 0.05) ,the treatment group decreased more significantly (P 〈 0.01), HDL-C and HDL2 of the treatment group decreased significantly (P 〈 0.05) ,HDL3 and HDL3/HDL-C increased obviously (P 〈0.05). HDL-C of the control group increased significantly (P〈 0.05). Compared with the control group after treatment, TG,TC, LDL-C, HDL-C and HDL2 decreased more significantly (P 〈0.05), HDLa and HDL3/HDL-C increased more significantly in the treatment group (P 〈0.05). Conclusion Patients with ACS and type-2 diabetes treated with probucol combined with atorvastatin can reduce TG, TC and LDL-C, at the same time, although total HDL declines, HDLa with the ability of reverse transportation of TC increases.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2011年第9期808-810,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 国际动脉粥样硬化中国分会诺美基金(NMF2008-002)
关键词 普罗布考 胆固醇 HDL 甘油三酯类 急性冠状动脉综合征 糖尿病 2型 血小板聚集抑制剂 probucol cholesterol, HDL triglycerides acute coronary syndrome diabetes mellitus, type 2 platelet aggregation inhibitors
  • 相关文献

参考文献7

二级参考文献42

  • 1王东,丁华,徐红岩,魏欣冰.洛伐他汀、普罗布考对小鼠巨噬细胞源性泡沫细胞内胆固醇含量的影响[J].中国药理学通报,2004,20(6):680-684. 被引量:17
  • 2傅琛,夏强,曹春梅,高琴,姚慧,金红峰.活性氧、NO和线粒体ATP敏感钾通道在TNF-α预处理对缺血/再灌注心肌保护中的作用[J].中国应用生理学杂志,2005,21(1):20-24. 被引量:14
  • 3秦玲,赵学忠,张志国,薛建红.急性冠脉综合征患者细胞黏附分子和C反应蛋白的变化[J].吉林大学学报(医学版),2005,31(5):799-801. 被引量:15
  • 4孟晓萍,王超,孙健,费瑜,崔燕,王莉.急性冠状动脉综合征患者血清基质金属蛋白酶2水平的检测[J].中国动脉硬化杂志,2006,14(4):339-342. 被引量:16
  • 5Haffner SM, Miettinen H. Insulin resistance implications for type Ⅱdiabetes mellitus and coronary heart disease. Am J Med, 1997, 103:152-162.
  • 6Turner RC, Millns H, Nell HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus.United Kingdom Prospective Diabetes Study (UKPDS: 23).BMJ, 1998, 316:823-828.
  • 7Turner R, Cull C, Holman R, United Kingdom Prospective Diabetes Study 17: A 9-year update of a randomized controlled trial on the effect of improved metabolic control on complications in non-insulln-dependent diabetes mellitus. Ann Intern Med, 1996, 124: 136-145.
  • 8Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National cholesterol education programs Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel Ⅲ ). JAMA,2001, 285: 2486-2497.
  • 9Skoczynska A, Turczyn B, Kuliszkiewicz Janus M, et al. The utility of high density lipoprotein cholesterol subclasses measurement. Pol Arch Med Wewn, 2002, 107: 525-532.
  • 10Sakuma N, Yoshikawa M, Hibino T, et al. HDL3 exerts a more powerful antiperoxidative and protective effect against peroxidative modification of LDL than HDL2 does, J Nutr Sci Vitaminol (Tokyo), 2002, 48:278-282.

共引文献45

同被引文献57

  • 1曹建敏,王宗花,孙广平,丁明玉,杨学东,寇怀江.川芎中内酯类化学成分的提取与溶剂萃取分离方法研究[J].分析试验室,2005,24(9):59-62. 被引量:10
  • 2秦玲,雷宇,黄可欣.阿托伐他汀抗动脉粥样硬化的机制[J].高血压杂志,2006,14(6):461-465. 被引量:7
  • 3杨健,王卫淑.氧化低密度脂蛋白与动脉粥样硬化[J].山西医药杂志,2006,35(9):806-808. 被引量:5
  • 4戚国庆,贾彬,杜文涛,杨备战,夏岳,李永星,李博,魏立业.冠心病患者血清对氧磷酶1活性对氧化低密度脂蛋白水平的影响[J].临床荟萃,2006,21(24):1783-1784. 被引量:11
  • 5中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5221
  • 6Braunwald E,Autnan EM,Beasley JM,et al.ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial in farction:a report of the American College of Cardiology/American Heart Association task force on practice Guidelines[J].J Am coll Cardiol,2002,40(7):1366-1374.
  • 7Hong SC,Zhao SP,Wu ZY.Probucol Up-Regulates Paraoxonase 1 Expression in Hepatocytes of Hypercholesterolemic Rabbits[J].J Cardiovasc Pharmacol,2006,47(1):77-81.
  • 8Zhong JK,Guo ZG,Li C,et al.Probucol alleviates atherosclerosis and improves high density lipoprotein function[J].Lipids Health Dis,2011,10:210.
  • 9Harangi M,Mirdamadi HZ,Seres I,et al.Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity[J].Transl Res,2009,153(4):190-198.
  • 10Wang Y, Cheng KK, Lam KS, et al. APPL1 counteracts obesity- induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothe- lin-1 in mice. Diabetes, 2011,60 ( 11 ) : 3044-3054. doi: 10.2337/db11-0666.

引证文献5

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部